Join to view full profile
601 S Sherman StSpokane, WA 99202
Phone+1 509-228-1000
Fax+1 509-252-9300
Dr. Gersh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineResidency, Internal Medicine, 1975 - 1980
University of Colorado School of Medicine Anschutz Medical CampusClass of 1975
Certifications & Licensure
WA State Medical License 1980 - 2021
ID State Medical License 2012 - 2020
GA State Medical License 1977 - 1981
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Radiation Oncology), Varian Medical Systems, 2015-2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2015-2017
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2015-2017
Publications & Presentations
PubMed
- 30 citationsPRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinu...R Wendel Naumann, Robert L Coleman, Robert A Burger, Edward A Sausville, Elzbieta Kutarska
Journal of Clinical Oncology. 2013-12-10 - 43 citationsGemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative studyDonald A. Richards, Paul R. Kuefler, Carlos Becerra, Lalan S. Wilfong, Robert H. Gersh
Investigational New Drugs. 2011-02-01 - 215 citationsHematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic SyndromesRoger M. Lyons, Thomas Cosgriff, Sanjiv Modi, Robert H. Gersh, John D. Hainsworth
Journal of Clinical Oncology. 2009-04-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










